Related Articles
Diffuse mesothelin expression leads to worse prognosis through enhanced cellular proliferation in colorectal cancer
Hepatic metastasis from bile duct cancer of the ampulla is effectively controlled by multidisciplinary treatment including S-1, gemcitabine and bevacizumab: A case report
FXYD6 is a new biomarker of cholangiocarcinoma
Clinical impact of body composition on postoperative outcomes during neoadjuvant chemoradiation therapy for distal bile duct cancer
Ursodeoxycholic acid inhibits epithelial‑mesenchymal transition, suppressing invasiveness of bile duct cancer cells: An <em>in vitro</em> study